A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?
DiscussionThe inactivated SARS-CoV-2 vaccine (BBIBP-CorV) is a tolerable and effective method to prevent COVID-19.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer Vaccines | Covid Vaccine | COVID-19 | Endocrinology | Herceptin | Pain | SARS | Study | Vaccines